At the end of April 2022, Austria paid almost 475 million euros for vaccines to protect against Covid-19. This is apparent from the answer to a parliamentary question from the FPÖ from Health Minister Johannes Rauch (Greens). In total, about 37.87 million doses of vaccines were delivered to Austria, with the manufacturer BioNTech/Pfizer accounting for the most with 23.51 million.
AstraZeneca delivered approximately 5.52 million doses, nearly 4.93 million Moderna, nearly 2.62 million Novavax and 1.29 million Janssen (Johnson & Johnson). More than 44 percent of the vaccines received have not yet been vaccinated. According to the Ministry of Health, 16.7 million were in federal camps at the end of April. At that time, 517,880 vaccine doses were past their expiration date, of which 288,040 were from AstraZeneca, 192,230 from Moderna and 37,560 from BioNTech/Pfizer.
To date, Austria has donated nearly 7.4 million vaccine doses (as of May 6), of which 3.59 million vaccines from manufacturers AstraZeneca and Janssen (Johnson & Johnson) were donated to COVAX – an initiative ensuring equal and fair access to Covid worldwide -19 vaccines – passed. Bangladesh received more than 1.25 million doses of AstraZeneca, Iran one million, Bosnia and Herzegovina nearly 500,000, Ghana 345,000 and Ukraine 250,000.
15.82 euros cost for a single vaccination
In addition, as part of the so-called EU Vaccine Sharing Mechanism, Austria was actively involved in the coordinated transfer of about 650,000 Covid-19 vaccines to the countries of the Western Balkans, which was handled by the Ministry of Foreign Affairs.
As for the stored vaccines, the majority must be donated or “used for booster vaccinations” by the fall at the latest, says Health Minister Rauch. Incidentally, according to calculations by the ministry, each individual corona vaccination cost an average of 15.82 euros.
Source: Krone
I am Ida Scott, a journalist and content author with a passion for uncovering the truth. I have been writing professionally for Today Times Live since 2020 and specialize in political news. My career began when I was just 17; I had already developed a knack for research and an eye for detail which made me stand out from my peers.
